In some cases, they may not be available in every strength or form as the brand-name drug. Moxifloxacin belongs to a class of drugs called fluoroquinolones. A class of drugs is a group of ...

To report a newly recognized adverse effect of oral moxifloxacin. In five patients, a uveitis-like episode followed oral moxifloxacin therapy, afterwards they experienced photophobia. At slitlamp ...

Moxifloxacin (as HCl) 400mg/250mL; soln for IV infusion; latex- and preservative-free. Moxifloxacin inhibits topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial ...

Pharmacokinetic studies have been performed to identify possible drug-drug interactions involving moxifloxacin. [50,76,77,78,79,80,81] Concomitant administration of moxifloxacin and theophylline ...

Moxifloxacin is currently approved in more than 100 countries, including the United States, as a treatment for bacterial respiratory infections, such as bronchitis, sinusitis and pneumonia. Share ...

Early-phase and preclinical studies suggest that moxifloxacin-containing regimens could allow for effective 4-month treatment of uncomplicated, smear-positive pulmonary tuberculosis. We conducted ...

WASHINGTON — Hopes for a new, moxifloxacin-containing tuberculosis (TB) treatment that might have shortened therapy from 6 to 4 months suffered a setback today with the results of REMoxTB study ...

In one 4-month regimen, rifampin was replaced with rifapentine; in the other, rifampin was replaced with rifapentine and ethambutol with moxifloxacin. The primary efficacy outcome was survival ...